Greyledge Technologies
Greyledge Technologies, with a valuation of $25 million, is raising funds on StartEngine. It is a biotechnology company that is developing safe and effective autologous cell therapies. Greyledge Technologies’ research is focused on blood, bone marrow, and adipose cell therapy products, along with AI-driven data analysis and medical device automation. The business currently operates 11 processing labs across the US and Europe and plans to expand further to optimize treatment consistency through data-driven analytics. David Karli and Zoe Bedford founded Greyledge Technologies in October 2020. The current crowdfunding campaign has a minimum target of $124,000 and a maximum target of $1.24 million. The campaign proceeds will be used for research and development, company employment, and working capital.
Investment Overview
Raised: $154,863
Deal Terms
Total Commitments ($USD)
- Platform
- StartEngine
- Start Date
- 11/20/2024
- Close Date
- 02/18/2025
$124,000
$1,235,000
$500
Convertible Note
RegCF
$25,000,000
20%
Company & Team
Company
- Year Founded
- 2020
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Location
- Lone Tree, Colorado
- Company Website
-
Visit Website
Team
- Employees
- 5
Financials
-
Revenue
- $734,474
- Monthly Burn
- $157,005
-
Runway
- 4.5 months
- Gross Margin
- 86%
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 02/18/2025 | StartEngine | $25,000,000 | $154,863 | Convertible Note | Active | RegCF |